drugset / Trial / NCT00382174
Study of Thymosin Beta 4 in Patients With Pressure Ulcers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability and effectiveness of Thymosin Beta 4 administered topically in patients with Pressure Ulcers
Timeline
- Start
- 2006-05
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Thymosin Beta 4 | Peptide | 0.01 % | Topical |
| Comparator | Thymosin Beta 4 | Peptide | 0.02 % | Topical |
| Comparator | Thymosin Beta 4 | Peptide | 0.1 % | Topical |